Financial reports
10-K
2023 FY
Annual report
6 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
17 Apr 23
10-K
2022 FY
Annual report
23 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
10 Mar 22
Current reports
8-K
Departure of Directors or Certain Officers
15 Apr 24
8-K
Regulation FD Disclosure
11 Mar 24
8-K
Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results
6 Mar 24
8-K
Applied Therapeutics Announces $100 Million Private Placement
29 Feb 24
8-K
Other Events
15 Feb 24
8-K
Other Events
4 Jan 24
8-K
Other Events
3 Jan 24
8-K
Departure of Directors or Certain Officers
29 Dec 23
8-K
Departure of Directors or Certain Officers
17 Nov 23
8-K
Applied Therapeutics Reports Third Quarter 2023 Financial Results
9 Nov 23
Registration and prospectus
S-3
Shelf registration
22 Mar 24
D
$100.00 mm in equity / options, sold $100.00 mm, 31 investors
13 Mar 24
424B5
Prospectus supplement for primary offering
11 Aug 23
424B3
Prospectus supplement
19 May 23
S-3
Shelf registration
12 May 23
D
$30.00 mm in equity / options, sold $30.00 mm, 19 investors
5 May 23
S-8
Registration of securities for employees
23 Mar 23
424B5
Prospectus supplement for primary offering
24 Jun 22
424B5
Prospectus supplement for primary offering
22 Jun 22
424B5
Prospectus supplement for primary offering
26 Jan 22
Proxies
PRE 14A
Preliminary proxy
11 Apr 24
DEFA14A
Additional proxy soliciting materials
17 Apr 23
DEF 14A
Definitive proxy
17 Apr 23
DEFA14A
Additional proxy soliciting materials
9 Sep 22
DEF 14A
Definitive proxy
9 Sep 22
PRE 14A
Preliminary proxy
26 Aug 22
DEFA14A
Additional proxy soliciting materials
15 Apr 22
DEF 14A
Definitive proxy
15 Apr 22
DEFA14A
Additional proxy soliciting materials
21 Apr 21
DEF 14A
Definitive proxy
21 Apr 21
Other
UPLOAD
Letter from SEC
31 Jan 24
CORRESP
Correspondence with SEC
25 Jan 24
CORRESP
Correspondence with SEC
21 Dec 23
UPLOAD
Letter from SEC
7 Dec 23
EFFECT
Notice of effectiveness
22 May 23
CORRESP
Correspondence with SEC
17 May 23
UPLOAD
Letter from SEC
17 May 23
EFFECT
Notice of effectiveness
16 Jun 20
CORRESP
Correspondence with SEC
12 Jun 20
EFFECT
Notice of effectiveness
10 Jun 20
Ownership
4
Corwin Dale Hooks
15 Apr 24
3
Corwin Dale Hooks
15 Apr 24
4
Shoshana Shendelman
18 Mar 24
4
Riccardo Perfetti
18 Mar 24
4
Adam Hansard
18 Mar 24
4
Leslie D. Funtleyder
18 Mar 24
4
Constantine Chinoporos
18 Mar 24
3
Constantine Chinoporos
18 Mar 24
SC 13G
JANUS HENDERSON GROUP PLC
8 Mar 24
SC 13D/A
Shendelman Shoshana
5 Mar 24